Cleared Traditional

ARTIS pheno (VE2) (K201156) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
60d
Days
Class 2
Risk

K201156 is an FDA 510(k) clearance for the ARTIS pheno (VE2). Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by Siemens Medical Solution USA, Inc. (Malvern, US). The FDA issued a Cleared decision on June 29, 2020 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Siemens Medical Solution USA, Inc. devices

Submission Details

510(k) Number K201156 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 30, 2020
Decision Date June 29, 2020
Days to Decision 60 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 107d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 190
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K201156.
Alphenix, INFX-8000V/B, /S, V9.1
K203551 · Canon Medical Systems Corporation · Dec 2020
Ziehm Vision RFD 3D
K202360 · Ziehm Imaging GmbH · Sep 2020
Digiscan FDX
K200218 · Allengers Medical Systems Limited · Jul 2020
ControlRad Trace Model 9
K200663 · Controlrad, Inc. · Jun 2020
CFP-3131, CFP-2222
K201172 · Mx Imaging, Inc. · May 2020
Azurion R2.1
K200917 · Philips Medical Systems Nederland B.V. · May 2020